Artificial Intelligence in Drug Discovery
Today: #113 in Technology, India on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Artificial Intelligence in Drug…, try…
Ranking history · United States
Latest episodes
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
August 7, 2018 · 32 minOn this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. A new area of strategic focus is…
-
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
August 7, 2018 · 34 minOn this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based drugs such as antibodies and peptides. On…
-
Regina Barzilay, AI Small Molecule Discovery and Synthesis
July 30, 2018 · 29 minOn this episode, I speak with Regina Barzilay of MIT's Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly cited papers in machine learning. On…
-
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
July 26, 2018 · 38 minOn this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% faster and 90% cheaper. On this episode…
-
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
July 18, 2018 · 24 minOn this episode, I speak with John Cassidy, CEO of Cambridge Cancer Genomics ( www.ccg.ai ). CCG aims to transform oncology by combining liquid biopsy with genomics and artificial intelligence to predict disease progression and improve…
Show 7 more episodesShow fewer episodes
-
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
July 10, 2018 · 26 minOn this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the diseases for which aging puts people at…
-
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
June 28, 2018 · 24 minOn this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drugs. But that’s just the beginning. In…
-
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
June 20, 2018 · 32 minOn this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can integrate data from multiple sources to…
-
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
June 11, 2018 · 29 minOn this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before learning about ReviveMed, I knew little…
-
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
May 29, 2018 · 20 minOn this episode, I speak with Mostapha Benhenda of Startcrowd ( http://www.startcrowd.club ). In January, Mostapha wrote a controversial article critiquing several research labs ( https://bit.ly/2qINvQ9 ). Some accused him of using the…
-
Mauro Cozzi, Researchably, AI for Better Biomedical Search
May 22, 2018 · 30 minOn this episode, I speak with Mauro Cozzi, co-founder of Researchably ( www.researchably.com ). Researchably is a biomedical search engine that uses artificial intelligence to save researchers time—Mauro says up to 90%—searching for…
-
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
May 14, 2018 · 31 minFor the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA ( https://www.fdna.com/ ). FDNA enables precision medicine by using artificial intelligence for next-generation phenotyping…

Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom